Instructional Course - Requires Course Pass or Individual Course Ticket, Additional Registration Required
Treatment of renal cell carcinoma has changed with expanding indications for Robotic Partial nephrectomy and inclusion of new FDA approved treatments for advanced RCC. This course will focus on didactic case discussions using video tape analysis of surgical treatment, setup and successful completion of Robotic Partial nephrectomy, complication management and how to optimize outcomes. Urologists are now faced with treatment of advanced RCC with a host of options, from tyrosine kinase inhibitors to mtor inhibitors. This course will cover management of the high risk patient, when to start, what to monitor, and when to switch therapies. The contemporary urologist will need to know how to manage these advanced RCC patients.